ID   SGCE_HUMAN              Reviewed;         437 AA.
AC   O43556; B2R8N2; D6W5Q8; E9PF60; G5E9K6; Q6L8P0; Q75MH8; Q8NFG8; Q8WW28;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   07-JUL-2009, sequence version 6.
DT   18-JUN-2025, entry version 191.
DE   RecName: Full=Epsilon-sarcoglycan;
DE            Short=Epsilon-SG;
GN   Name=SGCE; Synonyms=ESG; ORFNames=UNQ433/PRO840;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Heart;
RX   PubMed=9475163; DOI=10.1016/s0014-5793(97)01593-7;
RA   McNally E.M., Ly C.T., Kunkel L.M.;
RT   "Human epsilon-sarcoglycan is highly related to alpha-sarcoglycan
RT   (adhalin), the limb girdle muscular dystrophy 2D gene.";
RL   FEBS Lett. 422:27-32(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Heart;
RA   Nigro V.;
RL   Submitted (JUL-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Dagvadorj A.;
RT   "Epsilon-sarcoglycan mutations in three ethnically diverse families
RT   segregating Myoclonus-Dystonia.";
RL   Submitted (MAY-2002) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A.,
RA   Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D.,
RA   Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L.,
RA   Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C.,
RA   Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J.,
RA   Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale effort to
RT   identify novel human secreted and transmembrane proteins: a bioinformatics
RT   assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain cortex;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K.,
RA   Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A.,
RA   Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H.,
RA   Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A.,
RA   Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P.,
RA   Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M.,
RA   Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S.,
RA   Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R.,
RA   Strowmatt C., Latreille P., Miller N., Johnson D., Murray J.,
RA   Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W.,
RA   Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A.,
RA   Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E.,
RA   Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A.,
RA   Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A.,
RA   Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R.,
RA   McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H.,
RA   Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS SER-49 AND
RP   HIS-399.
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 14-437 (ISOFORM 2), AND ALTERNATIVE SPLICING.
RC   TISSUE=Brain;
RX   PubMed=15193417; DOI=10.1016/j.molbrainres.2004.01.012;
RA   Nishiyama A., Endo T., Takeda S., Imamura M.;
RT   "Identification and characterization of epsilon-sarcoglycans in the central
RT   nervous system.";
RL   Brain Res. Mol. Brain Res. 125:1-12(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 293-437 (ISOFORM 1).
RX   PubMed=9405466; DOI=10.1074/jbc.272.51.32534;
RA   Ettinger A.J., Feng G., Sanes J.R.;
RT   "Epsilon-sarcoglycan, a broadly expressed homologue of the gene mutated in
RT   limb-girdle muscular dystrophy 2D.";
RL   J. Biol. Chem. 272:32534-32538(1997).
RN   [11]
RP   ERRATUM OF PUBMED:9405466.
RA   Ettinger A.J., Feng G., Sanes J.R.;
RL   J. Biol. Chem. 273:19922-19922(1998).
RN   [12]
RP   INVOLVEMENT IN DYT11.
RX   PubMed=11528394; DOI=10.1038/ng709;
RA   Zimprich A., Grabowski M., Asmus F., Naumann M., Berg D., Bertram M.,
RA   Scheidtmann K., Kern P., Winkelmann J., Muller-Myhsok B., Riedel L.,
RA   Bauer M., Muller T., Castro M., Meitinger T., Strom T.M., Gasser T.;
RT   "Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-
RT   dystonia syndrome.";
RL   Nat. Genet. 29:66-69(2001).
RN   [13]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-200.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of multiple
RT   enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [14]
RP   VARIANT DYT11 ARG-196.
RX   PubMed=12402271; DOI=10.1002/ana.10358;
RA   Klein C., Liu L., Doheny D., Kock N., Muller B., de Carvalho Aguiar P.,
RA   Leung J., de Leon D., Bressman S.B., Silverman J., Smith C., Danisi F.,
RA   Morrison C., Walker R.H., Velickovic M., Schwinger E., Kramer P.L.,
RA   Breakefield X.O., Brin M.F., Ozelius L.J.;
RT   "Epsilon-sarcoglycan mutations found in combination with other dystonia
RT   gene mutations.";
RL   Ann. Neurol. 52:675-679(2002).
RN   [15]
RP   VARIANT DYT11 ARG-60.
RX   PubMed=15258227; DOI=10.1136/jnnp.2003.027177;
RA   Schule B., Kock N., Svetel M., Dragasevic N., Hedrich K.,
RA   De Carvalho Aguiar P., Liu L., Kabakci K., Garrels J., Meyer E.M.,
RA   Berisavac I., Schwinger E., Kramer P.L., Ozelius L.J., Klein C., Kostic V.;
RT   "Genetic heterogeneity in ten families with myoclonus-dystonia.";
RL   J. Neurol. Neurosurg. Psych. 75:1181-1185(2004).
RN   [16]
RP   VARIANT DYT11 PRO-60.
RX   PubMed=15079037; DOI=10.1212/01.wnl.0000118286.75059.35;
RA   Hedrich K., Meyer E.M., Schule B., Kock N., de Carvalho Aguiar P.,
RA   Wiegers K., Koelman J.H., Garrels J., Durr R., Liu L., Schwinger E.,
RA   Ozelius L.J., Landwehrmeyer B., Stoessl A.J., Tijssen M.A., Klein C.;
RT   "Myoclonus-dystonia: detection of novel, recurrent, and de novo SGCE
RT   mutations.";
RL   Neurology 62:1229-1231(2004).
RN   [17]
RP   VARIANTS DYT11 THR-92; CYS-115 AND TYR-271.
RX   PubMed=16227522; DOI=10.1136/jmg.2005.036780;
RA   Tezenas du Montcel S., Clot F., Vidailhet M., Roze E., Damier P.,
RA   Jedynak C.P., Camuzat A., Lagueny A., Vercueil L., Doummar D.,
RA   Guyant-Marechal L., Houeto J.L., Ponsot G., Thobois S., Cournelle M.A.,
RA   Durr A., Durif F., Echenne B., Hannequin D., Tranchant C., Brice A.;
RT   "Epsilon sarcoglycan mutations and phenotype in French patients with
RT   myoclonic syndromes.";
RL   J. Med. Genet. 43:394-400(2006).
RN   [18]
RP   VARIANT DYT11 ARG-112.
RX   PubMed=17853490; DOI=10.1002/mds.21715;
RA   Nardocci N., Zorzi G., Barzaghi C., Zibordi F., Ciano C., Ghezzi D.,
RA   Garavaglia B.;
RT   "Myoclonus-dystonia syndrome: clinical presentation, disease course, and
RT   genetic features in 11 families.";
RL   Mov. Disord. 23:28-34(2008).
RN   [19]
RP   VARIANTS DYT11 ARG-36 AND PRO-184.
RX   PubMed=18175340; DOI=10.1002/mds.21785;
RA   Raymond D., Saunders-Pullman R., de Carvalho Aguiar P., Schule B., Kock N.,
RA   Friedman J., Harris J., Ford B., Frucht S., Heiman G.A., Jennings D.,
RA   Doheny D., Brin M.F., de Leon Brin D., Multhaupt-Buell T., Lang A.E.,
RA   Kurlan R., Klein C., Ozelius L., Bressman S.;
RT   "Phenotypic spectrum and sex effects in eleven myoclonus-dystonia families
RT   with epsilon-sarcoglycan mutations.";
RL   Mov. Disord. 23:588-592(2008).
RN   [20]
RP   VARIANTS DYT11 GLY-100 AND CYS-115.
RX   PubMed=18362280; DOI=10.1212/01.wnl.0000297516.98574.c0;
RA   Roze E., Apartis E., Clot F., Dorison N., Thobois S., Guyant-Marechal L.,
RA   Tranchant C., Damier P., Doummar D., Bahi-Buisson N., Andre-Obadia N.,
RA   Maltete D., Echaniz-Laguna A., Pereon Y., Beaugendre Y., Dupont S.,
RA   De Greslan T., Jedynak C.P., Ponsot G., Dussaule J.C., Brice A., Durr A.,
RA   Vidailhet M.;
RT   "Myoclonus-dystonia: clinical and electrophysiologic pattern related to
RT   SGCE mutations.";
RL   Neurology 70:1010-1016(2008).
RN   [21]
RP   VARIANTS DYT11 SER-175; CYS-177 AND ARG-270.
RX   PubMed=19066193; DOI=10.1136/jnnp.2008.162099;
RA   Ritz K., Gerrits M.C., Foncke E.M., van Ruissen F., van der Linden C.,
RA   Vergouwen M.D., Bloem B.R., Vandenberghe W., Crols R., Speelman J.D.,
RA   Baas F., Tijssen M.A.;
RT   "Myoclonus-dystonia: clinical and genetic evaluation of a large cohort.";
RL   J. Neurol. Neurosurg. Psych. 80:653-658(2009).
RN   [22]
RP   CHARACTERIZATION OF VARIANTS DYT11 ARG-60; PRO-60; THR-92; CYS-115; ARG-270
RP   AND TYR-271.
RX   PubMed=21796726; DOI=10.1002/humu.21561;
RA   Waite A., De Rosa M.C., Brancaccio A., Blake D.J.;
RT   "A gain-of-glycosylation mutation associated with myoclonus-dystonia
RT   syndrome affects trafficking and processing of mouse epsilon-sarcoglycan in
RT   the late secretory pathway.";
RL   Hum. Mutat. 32:1246-1258(2011).
CC   -!- FUNCTION: Component of the sarcoglycan complex, a subcomplex of the
CC       dystrophin-glycoprotein complex which forms a link between the F-actin
CC       cytoskeleton and the extracellular matrix.
CC   -!- SUBCELLULAR LOCATION: Cell membrane, sarcolemma {ECO:0000250}; Single-
CC       pass membrane protein {ECO:0000250}. Cytoplasm, cytoskeleton
CC       {ECO:0000250}. Cell projection, dendrite {ECO:0000250}. Golgi apparatus
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=epsilon-SG1;
CC         IsoId=O43556-1; Sequence=Displayed;
CC       Name=2; Synonyms=epsilon-SG2;
CC         IsoId=O43556-3; Sequence=VSP_045092, VSP_045093;
CC       Name=3;
CC         IsoId=O43556-4; Sequence=VSP_054079;
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- PTM: N-glycosylated. {ECO:0000250}.
CC   -!- PTM: Ubiquitinated, leading to its degradation by the proteasome.
CC       {ECO:0000250}.
CC   -!- DISEASE: Dystonia 11, myoclonic (DYT11) [MIM:159900]: A myoclonic
CC       dystonia. Dystonia is defined by the presence of sustained involuntary
CC       muscle contractions, often leading to abnormal postures. DYT11 is
CC       characterized by involuntary lightning jerks and dystonic movements and
CC       postures alleviated by alcohol. Inheritance is autosomal dominant. The
CC       age of onset, pattern of body involvement, presence of myoclonus and
CC       response to alcohol are all variable. {ECO:0000269|PubMed:11528394,
CC       ECO:0000269|PubMed:12402271, ECO:0000269|PubMed:15079037,
CC       ECO:0000269|PubMed:15258227, ECO:0000269|PubMed:16227522,
CC       ECO:0000269|PubMed:17853490, ECO:0000269|PubMed:18175340,
CC       ECO:0000269|PubMed:18362280, ECO:0000269|PubMed:19066193,
CC       ECO:0000269|PubMed:21796726}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: [Isoform 2]: Brain-specific. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the sarcoglycan alpha/epsilon family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC04368.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAD21206.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF036364; AAC04368.1; ALT_INIT; mRNA.
DR   EMBL; AJ000534; CAA04167.1; -; mRNA.
DR   EMBL; AF516515; AAM64204.1; -; mRNA.
DR   EMBL; AY359042; AAQ89401.1; -; mRNA.
DR   EMBL; AK313438; BAG36229.1; -; mRNA.
DR   EMBL; AC069292; AAS07485.1; -; Genomic_DNA.
DR   EMBL; CH471091; EAW76784.1; -; Genomic_DNA.
DR   EMBL; CH471091; EAW76785.1; -; Genomic_DNA.
DR   EMBL; CH471091; EAW76786.1; -; Genomic_DNA.
DR   EMBL; CH471091; EAW76788.1; -; Genomic_DNA.
DR   EMBL; BC021709; AAH21709.1; -; mRNA.
DR   EMBL; AB117974; BAD21206.1; ALT_INIT; mRNA.
DR   EMBL; AF031920; AAC14021.1; -; mRNA.
DR   CCDS; CCDS47642.1; -. [O43556-3]
DR   CCDS; CCDS47643.1; -. [O43556-4]
DR   CCDS; CCDS5637.1; -. [O43556-1]
DR   RefSeq; NP_001092870.1; NM_001099400.2. [O43556-3]
DR   RefSeq; NP_001092871.1; NM_001099401.2. [O43556-4]
DR   RefSeq; NP_001288068.1; NM_001301139.1.
DR   RefSeq; NP_003910.1; NM_003919.3. [O43556-1]
DR   AlphaFoldDB; O43556; -.
DR   SMR; O43556; -.
DR   BioGRID; 114424; 30.
DR   ComplexPortal; CPX-2453; Dystrophin glycoprotein complex, CNS variant.
DR   CORUM; O43556; -.
DR   FunCoup; O43556; 291.
DR   IntAct; O43556; 19.
DR   STRING; 9606.ENSP00000496268; -.
DR   GlyConnect; 1218; 2 N-Linked glycans (1 site).
DR   GlyCosmos; O43556; 1 site, 2 glycans.
DR   GlyGen; O43556; 1 site, 5 N-linked glycans (1 site).
DR   iPTMnet; O43556; -.
DR   PhosphoSitePlus; O43556; -.
DR   SwissPalm; O43556; -.
DR   BioMuta; SGCE; -.
DR   jPOST; O43556; -.
DR   MassIVE; O43556; -.
DR   PaxDb; 9606-ENSP00000398930; -.
DR   PeptideAtlas; O43556; -.
DR   ProteomicsDB; 20035; -.
DR   ProteomicsDB; 33967; -.
DR   ProteomicsDB; 49048; -. [O43556-1]
DR   Pumba; O43556; -.
DR   Antibodypedia; 30109; 143 antibodies from 27 providers.
DR   DNASU; 8910; -.
DR   Ensembl; ENST00000445866.7; ENSP00000398930.2; ENSG00000127990.19. [O43556-4]
DR   Ensembl; ENST00000642933.1; ENSP00000496237.1; ENSG00000127990.19. [O43556-3]
DR   Ensembl; ENST00000648936.2; ENSP00000497130.1; ENSG00000127990.19. [O43556-1]
DR   GeneID; 8910; -.
DR   KEGG; hsa:8910; -.
DR   MANE-Select; ENST00000648936.2; ENSP00000497130.1; NM_003919.3; NP_003910.1.
DR   UCSC; uc003unl.3; human. [O43556-1]
DR   AGR; HGNC:10808; -.
DR   CTD; 8910; -.
DR   DisGeNET; 8910; -.
DR   GeneCards; SGCE; -.
DR   GeneReviews; SGCE; -.
DR   HGNC; HGNC:10808; SGCE.
DR   HPA; ENSG00000127990; Low tissue specificity.
DR   MalaCards; SGCE; -.
DR   MIM; 159900; phenotype.
DR   MIM; 604149; gene.
DR   neXtProt; NX_O43556; -.
DR   OpenTargets; ENSG00000127990; -.
DR   Orphanet; 36899; Myoclonus-dystonia syndrome.
DR   PharmGKB; PA35719; -.
DR   VEuPathDB; HostDB:ENSG00000127990; -.
DR   eggNOG; KOG4482; Eukaryota.
DR   GeneTree; ENSGT00390000005672; -.
DR   InParanoid; O43556; -.
DR   OrthoDB; 10019906at2759; -.
DR   PAN-GO; O43556; 1 GO annotation based on evolutionary models.
DR   PhylomeDB; O43556; -.
DR   TreeFam; TF314655; -.
DR   PathwayCommons; O43556; -.
DR   Reactome; R-HSA-9913351; Formation of the dystrophin-glycoprotein complex (DGC).
DR   SignaLink; O43556; -.
DR   BioGRID-ORCS; 8910; 38 hits in 1153 CRISPR screens.
DR   ChiTaRS; SGCE; human.
DR   GeneWiki; SGCE; -.
DR   GenomeRNAi; 8910; -.
DR   Pharos; O43556; Tbio.
DR   PRO; PR:O43556; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   RNAct; O43556; protein.
DR   Bgee; ENSG00000127990; Expressed in tendon of biceps brachii and 207 other cell types or tissues.
DR   ExpressionAtlas; O43556; baseline and differential.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0032590; C:dendrite membrane; ISS:UniProtKB.
DR   GO; GO:0016010; C:dystrophin-associated glycoprotein complex; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0016012; C:sarcoglycan complex; IBA:GO_Central.
DR   GO; GO:0042383; C:sarcolemma; IEA:UniProtKB-SubCell.
DR   GO; GO:0007160; P:cell-matrix adhesion; TAS:ProtInc.
DR   GO; GO:0007517; P:muscle organ development; TAS:ProtInc.
DR   InterPro; IPR006644; Cadg.
DR   InterPro; IPR008908; Sarcoglycan_alpha/epsilon.
DR   InterPro; IPR048347; Sarcoglycan_C.
DR   InterPro; IPR048346; Sarcoglycan_N.
DR   PANTHER; PTHR10132; ALPHA-/EPSILON-SARCOGLYCAN FAMILY MEMBER; 1.
DR   PANTHER; PTHR10132:SF17; EPSILON-SARCOGLYCAN; 1.
DR   Pfam; PF05510; Sarcoglycan_2; 1.
DR   Pfam; PF20989; Sarcoglycan_2_C; 1.
DR   SMART; SM00736; CADG; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Cell projection; Cytoplasm;
KW   Cytoskeleton; Disease variant; Dystonia; Glycoprotein; Golgi apparatus;
KW   Membrane; Proteomics identification; Reference proteome; Transmembrane;
KW   Transmembrane helix; Ubl conjugation.
FT   CHAIN           1..437
FT                   /note="Epsilon-sarcoglycan"
FT                   /id="PRO_0000031677"
FT   TOPO_DOM        1..317
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        318..338
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        339..437
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        200
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19159218"
FT   VAR_SEQ         347..355
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15193417"
FT                   /id="VSP_045092"
FT   VAR_SEQ         418
FT                   /note="Q -> QWSFAPVAQAGVQWSDLGSLQPPPPR (in isoform 3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_054079"
FT   VAR_SEQ         434..437
FT                   /note="KWYP -> DFRLTTFQRFEVNGIPEERKLTEAMNL (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15193417"
FT                   /id="VSP_045093"
FT   VARIANT         36
FT                   /note="T -> R (in DYT11)"
FT                   /evidence="ECO:0000269|PubMed:18175340"
FT                   /id="VAR_066732"
FT   VARIANT         49
FT                   /note="N -> S (in dbSNP:rs11548284)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_058088"
FT   VARIANT         60
FT                   /note="H -> P (in DYT11; affects protein stability; the
FT                   mutant undergoes endoplasmic reticulum-associated
FT                   degradation)"
FT                   /evidence="ECO:0000269|PubMed:15079037,
FT                   ECO:0000269|PubMed:21796726"
FT                   /id="VAR_066733"
FT   VARIANT         60
FT                   /note="H -> R (in DYT11; affects protein stability; the
FT                   mutant undergoes endoplasmic reticulum-associated
FT                   degradation)"
FT                   /evidence="ECO:0000269|PubMed:15258227,
FT                   ECO:0000269|PubMed:21796726"
FT                   /id="VAR_066734"
FT   VARIANT         92
FT                   /note="M -> T (in DYT11; results in gain-of-glycosylation;
FT                   the mutant is targeted to the plasma membrane at reduced
FT                   levels compared to wild-type; dbSNP:rs1804082499)"
FT                   /evidence="ECO:0000269|PubMed:16227522,
FT                   ECO:0000269|PubMed:21796726"
FT                   /id="VAR_066735"
FT   VARIANT         100
FT                   /note="W -> G (in DYT11)"
FT                   /evidence="ECO:0000269|PubMed:18362280"
FT                   /id="VAR_066736"
FT   VARIANT         112
FT                   /note="G -> R (in DYT11)"
FT                   /evidence="ECO:0000269|PubMed:17853490"
FT                   /id="VAR_066737"
FT   VARIANT         115
FT                   /note="Y -> C (in DYT11; affects protein stability; the
FT                   mutant undergoes endoplasmic reticulum-associated
FT                   degradation; dbSNP:rs2116958989)"
FT                   /evidence="ECO:0000269|PubMed:16227522,
FT                   ECO:0000269|PubMed:18362280, ECO:0000269|PubMed:21796726"
FT                   /id="VAR_066738"
FT   VARIANT         175
FT                   /note="L -> S (in DYT11)"
FT                   /evidence="ECO:0000269|PubMed:19066193"
FT                   /id="VAR_066739"
FT   VARIANT         177
FT                   /note="S -> C (in DYT11)"
FT                   /evidence="ECO:0000269|PubMed:19066193"
FT                   /id="VAR_066740"
FT   VARIANT         184
FT                   /note="L -> P (in DYT11; affects protein stability; the
FT                   mutant undergoes endoplasmic reticulum-associated
FT                   degradation; dbSNP:rs1064794321)"
FT                   /evidence="ECO:0000269|PubMed:18175340"
FT                   /id="VAR_066741"
FT   VARIANT         196
FT                   /note="L -> R (in DYT11; dbSNP:rs121908491)"
FT                   /evidence="ECO:0000269|PubMed:12402271"
FT                   /id="VAR_026750"
FT   VARIANT         270
FT                   /note="W -> R (in DYT11; affects protein stability; the
FT                   mutant undergoes endoplasmic reticulum-associated
FT                   degradation)"
FT                   /evidence="ECO:0000269|PubMed:19066193,
FT                   ECO:0000269|PubMed:21796726"
FT                   /id="VAR_066742"
FT   VARIANT         271
FT                   /note="C -> Y (in DYT11; affects protein stability; the
FT                   mutant undergoes endoplasmic reticulum-associated
FT                   degradation; dbSNP:rs372686312)"
FT                   /evidence="ECO:0000269|PubMed:16227522,
FT                   ECO:0000269|PubMed:21796726"
FT                   /id="VAR_066743"
FT   VARIANT         399
FT                   /note="P -> H (in dbSNP:rs17851923)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_058089"
FT   CONFLICT        78
FT                   /note="G -> S (in Ref. 3; AAM64204)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   437 AA;  49851 MW;  0996CB18272DED44 CRC64;
     MQLPRWWELG DPCAWTGQGR GTRRMSPATT GTFLLTVYSI FSKVHSDRNV YPSAGVLFVH
     VLEREYFKGE FPPYPKPGEI SNDPITFNTN LMGYPDRPGW LRYIQRTPYS DGVLYGSPTA
     ENVGKPTIIE ITAYNRRTFE TARHNLIINI MSAEDFPLPY QAEFFIKNMN VEEMLASEVL
     GDFLGAVKNV WQPERLNAIN ITSALDRGGR VPLPINDLKE GVYVMVGADV PFSSCLREVE
     NPQNQLRCSQ EMEPVITCDK KFRTQFYIDW CKISLVDKTK QVSTYQEVIR GEGILPDGGE
     YKPPSDSLKS RDYYTDFLIT LAVPSAVALV LFLILAYIMC CRREGVEKRN MQTPDIQLVH
     HSAIQKSTKE LRDMSKNREI AWPLSTLPVF HPVTGEIIPP LHTDNYDSTN MPLMQTQQNL
     PHQTQIPQQQ TTGKWYP
//
